You have 9 free searches left this month | for more free features.

Selumetinib, Differentiated Thyroid Cancer , AZD6244

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

Completed
  • Stage III Colorectal Cancer AJCC v8
  • +7 more
  • Biopsy
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Microbiome on Breast Cancer Radiotherapy Toxicity

Recruiting
  • DCIS
  • Invasive Breast Cancer
  • Stool sample
  • Skin Swab Sample
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023

Breast Cancer Trial in United States (drug, procedure, radiation)

Active, not recruiting
  • Breast Cancer
  • Canton, Ohio
  • +8 more
Jan 30, 2023

Integrated Chinese Medicine With Western Medicine for Reduction

Completed
  • Myelosuppression
  • Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment
  • (no location specified)
Jun 28, 2022

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

Pancreatic Cancer Trial in Tampa (Fitbit Data Collection, Nutrition Counseling, Fact G Survey)

Recruiting
  • Pancreatic Cancer
  • Fitbit Data Collection
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 29, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)

Not yet recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Intravenous Tislelizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Feb 21, 2022

DevelopingNew MRI Technique to Understand Changes in Brain

Recruiting
  • Brain Metastases
  • +3 more
  • CEST-MRF
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 27, 2022

Cancer Trial in Strasbourg (Snoezelen session)

Recruiting
  • Cancer
  • Snoezelen session
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Aug 2, 2022

Colonic Tumors Malignant Trial in Russian Federation (Colonic resection with D2 lymph node dissection, Colonic resection with D3

Active, not recruiting
  • Colonic Neoplasms Malignant
  • Colonic resection with D2 lymph node dissection
  • Colonic resection with D3 lymph node dissection
  • Krasnodar, Russian Federation
  • +11 more
Apr 20, 2022

Colorectal Cancer Trial in Chengdu (lidocaine, Placebo)

Recruiting
  • Colorectal Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jun 24, 2023

Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)

Approved for marketing
  • Prostatic Neoplasms
  • +4 more
  • 68GA PSMA-HBED-CC
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 11, 2022

CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

Recruiting
  • CAR T-Cell Therapy
  • HEC-016(0.5×10^6 CAR-T Cells)
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Luohu Hospital
Mar 3, 2022

Target Therapy for Brain Metastases With EGFR Mutation

Not yet recruiting
  • Brain Metastases
  • Surgery or Radiotherapy
  • before or after target therapy
  • (no location specified)
Nov 8, 2022

Tobacco-Related Carcinoma Trial in United States (Best Practice, Survey Administration, Tobacco Cessation Counseling)

Recruiting
  • Tobacco-Related Carcinoma
  • Best Practice
  • +3 more
  • Lexington, Kentucky
  • +3 more
Apr 23, 2022

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)

Recruiting
  • Triple Negative Breast Cancer
  • Amadora, Lisboa, Portugal
  • +16 more
Jun 10, 2022

Rheumatoid Arthritis Trial in Saint Paul (Atorvastatin, Pravastatin, Rosuvastatin)

Completed
  • Rheumatoid Arthritis
  • Saint Paul, Minnesota
    Prism Research, LLC
May 26, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Rectal Cancer Trial in Montpellier, Clermont-Ferrand (Biological collection)

Recruiting
  • Rectal Cancer
  • Biological collection
  • Montpellier, Hérault, France
  • +1 more
Jan 21, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Social Experiences of Adolescents and Young Adults With Cancer

Recruiting
  • Childhood Cancer
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 1, 2022

    Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

    Active, not recruiting
    • Breast Cancer
    • Barcelona, Spain
    • +3 more
    Sep 27, 2022